Covered recipient · General Payments record
BRIJESH S BODIWALA
Allopathic & Osteopathic Physicians Internal Medicine Nephrology
General Payments · PY2018–2024
$879.14
- Reported across 44 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $177.64 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $69.11 | 4 |
| Ardelyx, Inc. | $61.20 | 3 |
| Otsuka America Pharmaceutical, Inc. | $31.86 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $15.47 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Ardelyx, Inc. | $22.24 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146672131 | CMS |
| Ardelyx, Inc. | $18.16 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146672134 | CMS |
| Ardelyx, Inc. | $20.80 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146672136 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.85 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105554236 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.46 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104372703 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.92 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105538867 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.88 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105549940 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $15.47 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086219551 | CMS |
| Otsuka America Pharmaceutical, Inc. | $31.86 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118863951 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.